Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Vomeronasal receptors (VRs) are a specialized class of G protein-coupled receptors (GPCRs) primarily located in the vomeronasal organ (VNO), which is part of the accessory olfactory system in most vertebrates [1][3]. These receptors are categorized into two distinct families: V1Rs, which are rhodopsin-like and detect small volatile molecules, and V2Rs, which are glutamate-like and detect larger water-soluble peptides [1][2]. Their primary biological function is the detection of pheromones and kairomones, which triggers innate social and reproductive behaviors such as mating, aggression, and territorial defense [3]. In humans, the VNO is largely considered vestigial, and the majority of VR genes have become pseudogenes, although a few functional V1R-like genes (e.g., VN1R1) are expressed in the main olfactory epithelium [4]. While research has explored the impact of putative human pheromones on brain activity and mood, no therapeutic drugs currently target these receptors [5]. Consequently, VRs are not established therapeutic targets in clinical medicine, though they remain significant in the study of mammalian behavior and chemosensory evolution [3][4].
Vomeronasal receptors function through G protein-coupled signaling; V1Rs typically couple with Gai2, while V2Rs couple with Gao, both leading to the activation of phospholipase C and the subsequent opening of TRPC2 cation channels, which depolarizes the sensory neuron [1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Vomeronasal receptor (VR) (VR).